Department of Biomaterials, Radboud University Nijmegen Medical Center, Philips van Leydenlaan 25, Nijmegen, The Netherlands.
Biomacromolecules. 2010 Oct 11;11(10):2653-9. doi: 10.1021/bm1006344.
Gelatin microspheres are well-known for their capacity to release growth factors in a controlled manner, but gelatin microspheres do not calcify in the absence of so-called bioactive substances that induce deposition of calcium phosphate (CaP) bone mineral. This study has investigated if CaP nanocrystals can be incorporated into gelatin microspheres to render these inert microspheres bioactive without compromising the drug releasing properties of gelatin microspheres. Incorporation of CaP nanocrystals into gelatin microspheres resulted into reduced biodegradation and drug release rates, whereas their calcifying capacity increased strongly compared to inert gelatin microspheres. The reduced drug release rate was correlated to the reduced degradation rate as caused by a physical cross-linking effect of CaP nanocrystals dispersed in the gelatin matrix. Consequently, these composite microspheres combine beneficial drug-releasing properties of organic gelatin with the calcifying capacity of a dispersed CaP phase.
明胶微球以其能够以可控的方式释放生长因子而闻名,但在没有所谓的诱导磷酸钙 (CaP) 骨矿物质沉积的生物活性物质的情况下,明胶微球不会钙化。本研究探讨了是否可以将 CaP 纳米晶体掺入明胶微球中,使这些惰性微球具有生物活性,而不会损害明胶微球的药物释放特性。将 CaP 纳米晶体掺入明胶微球中会导致生物降解和药物释放速率降低,而与惰性明胶微球相比,其钙化能力大大增强。药物释放率的降低与降解率的降低有关,这是由于分散在明胶基质中的 CaP 纳米晶体的物理交联作用所致。因此,这些复合微球将有机明胶的有益药物释放特性与分散的 CaP 相的钙化能力结合在一起。